Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis

Objective: To determine whether characterisation of patients' metabolic profiles, utilising nuclear magnetic resonance (NMR) and mass spectrometry (MS), could predict response to rituximab therapy. 23 patients with active, seropositive rheumatoid arthritis (RA) on concomitant methotrexate were...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:RMD Open
Autors principals: Sweeney, Shannon R, Kavanaugh, Arthur, Lodi, Alessia, Wang, Bo, Boyle, David, Tiziani, Stefano, Guma, Monica
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2016
Matèries:
Rheumatoid Arthritis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013418/
https://ncbi.nlm.nih.gov/pubmed/27651926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2016-000289
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars